Neurodegenerative disease - Molecular Mechanisms Underlying Neurodegeneration

Molecular and Cellular Mechanisms of Neurodegeneration Introduction Neurodegenerative diseases share common underlying mechanisms despite being caused by different genetic mutations and affecting different brain regions. Understanding these molecular and cellular processes is crucial because they represent the actual biological pathways leading to neuronal death and disease progression. This section explores the key mechanisms that drive neurodegeneration: how genes cause disease, how proteins misfold and aggregate, how cells attempt to clean up toxic proteins, and how cellular machinery fails in ways that kill neurons. Genetic Causes: CAG Repeat Expansions Many neurodegenerative diseases have specific genetic origins. While different genes cause different diseases, one pattern appears repeatedly: trinucleotide repeat expansion, particularly expansion of the CAG repeat sequence. What is a CAG Repeat? CAG is a three-nucleotide sequence that codes for the amino acid glutamine. Normally, genes contain a certain number of CAG repeats. In healthy individuals, these repeats are few and cause no problems. However, in some people, the CAG sequence can expand—repeating many more times than normal. This creates a long stretch of glutamine amino acids, called a polyglutamine tract. The Pathogenic Mechanism A polyglutamine tract is inherently abnormal. Proteins containing abnormally long polyglutamine stretches tend to: Misfold into incorrect three-dimensional shapes Degrade improperly, creating toxic fragments Localize incorrectly to wrong cellular compartments Interact abnormally with other proteins in harmful ways These problems accumulate and trigger cellular dysfunction. Diseases Caused by CAG Expansion At least nine inherited neurodegenerative diseases are caused by CAG repeat expansion, including: Huntington's disease (mutations in the HTT gene) Multiple spinocerebellar ataxias (various genes) The key point is that CAG expansion is a dominant pathogenic mechanism—just one mutated copy of the gene is enough to cause disease. Protein Misfolding and Proteopathy Defining Proteopathy The term proteopathy literally means "disease of proteins." Neurodegenerative diseases are classified as proteopathies because they fundamentally involve the aggregation of misfolded proteins into toxic, insoluble deposits within or around neurons. Why Protein Misfolding Matters Proteins normally fold into precise three-dimensional shapes that determine their function. Misfolded proteins can no longer perform their normal roles and instead interact with other proteins in harmful ways, triggering a cascade of cellular damage. Major Protein Aggregates in Neurodegeneration Different neurodegenerative diseases are characterized by different protein aggregates: Alpha-synuclein aggregates Alpha-synuclein is a small protein normally found in neurons. When misfolded, it forms insoluble fibrils that accumulate into structures called Lewy bodies. Lewy bodies are the pathological hallmark of: Parkinson's disease Dementia with Lewy bodies Multiple system atrophy Tau tangles The tau protein normally stabilizes microtubules (part of the neuronal cytoskeleton). When abnormally phosphorylated (modified by adding phosphate groups), tau proteins aggregate into neurofibrillary tangles. These tangles are characteristic of: Alzheimer's disease (where tau tangles coexist with other pathology) Pick's disease and other forms of frontotemporal dementia Amyloid-beta plaques Amyloid-beta (Aβ) is a peptide that accumulates into amyloid plaques, which are the primary extracellular pathological feature of Alzheimer's disease. These plaques form outside neurons. Prion protein aggregates In prion diseases (transmissible spongiform encephalopathies), the prion protein misfolds and aggregates. Critically, these aggregates are infectious—they can convert normal prion protein into the misfolded form, spreading disease throughout the brain and even between individuals. Intracellular Protein Degradation Pathways The Protein Garbage Disposal Problem Neurons constantly produce proteins, and old or damaged proteins must be removed. This is particularly critical in neurodegenerative diseases where toxic proteins accumulate. Cells have evolved two main systems to degrade and remove unwanted proteins. The Ubiquitin-Proteasome System (UPS) The ubiquitin-proteasome system is like a cellular "tagging and disposal" system: Proteins destined for destruction are tagged with a small protein called ubiquitin Tagged proteins are delivered to the proteasome, a large protein complex that acts as a molecular shredder The proteasome breaks down the tagged protein into small amino acid pieces The Problem in Neurodegeneration: The proteasome works well for normally shaped proteins, but struggles with abnormal substrates. For example: Polyglutamine expansions (from Huntington's disease) have irregular shapes that proteasomes cannot fully degrade Alpha-synuclein resists complete proteasomal degradation When proteasomes partially degrade these proteins, they may actually generate more toxic fragments rather than eliminating toxicity This is a paradoxical situation: the cellular defense system can make things worse. The Autophagy-Lysosome Pathway Autophagy is a "bulk disposal" system that complements the proteasome. The term literally means "self-eating." There are two important types: Macroautophagy (general autophagy) Large structures within the cell (called autophagosomes) engulf proteins, protein aggregates, and even damaged organelles These structures fuse with lysosomes (cellular compartments containing digestive enzymes) The contents are broken down completely Macroautophagy is particularly important for removing large protein aggregates and clearing dysfunctional mitochondria In mouse models with defective macroautophagy, ubiquitinated inclusion bodies accumulate and neurons degenerate Chaperone-mediated autophagy (selective autophagy) Chaperone proteins recognize and bind specific soluble proteins needing degradation These protein-chaperone complexes dock at receptors on the lysosomal membrane The proteins are pulled through the lysosomal membrane for degradation This pathway is highly selective and efficient A Critical Problem in Neurodegeneration: Mutant proteins can actually block chaperone-mediated autophagy by occupying the lysosomal receptors. Once these receptors are blocked: The mutant protein itself cannot be degraded Other normal substrates that depend on this pathway also cannot be degraded This creates a cascading failure where one defective protein poisons the entire degradation system Membrane Damage How Misfolded Proteins Damage Membranes Protein aggregates don't just sit inertly in cells—they actively damage cellular membranes. Even individual misfolded protein molecules or small clusters (oligomers) can cause significant harm. Alpha-Synuclein and Membrane Disruption Alpha-synuclein, particularly in its misfolded forms, interacts directly with lipid membranes: Membrane curvature: Alpha-synuclein induces abnormal bending and warping of membrane surfaces Tubulation: The protein causes membranes to form tube-like protrusions Vesiculation: Membrane fragments bud off as abnormal vesicles Pore formation: Most critically, alpha-synuclein can form nanoscale pores in lipid bilayers—essentially creating holes in the membrane Consequences of Membrane Damage When membranes are perforated or structurally compromised: Cellular integrity is disrupted: The barrier function of membranes fails Ion gradients collapse: Uncontrolled movement of ions (sodium, potassium, calcium) across the damaged membrane Cell death pathways activate: Membrane damage triggers apoptosis and other death cascades Organelle dysfunction: Damage to mitochondrial or lysosomal membranes spreads the problem Mitochondrial Dysfunction and Oxidative Stress Why Mitochondria Matter in Neurodegeneration Mitochondria are the powerhouse organelles that generate ATP (cellular energy) through respiration. They also control multiple critical cellular processes. Mitochondrial dysfunction is central to neurodegeneration. Reactive Oxygen Species and Oxidative Stress During normal mitochondrial respiration, reactive oxygen species (ROS) are produced as byproducts. ROS are highly reactive molecules containing unpaired electrons. In small amounts, cells handle ROS with antioxidant defenses (enzymes like superoxide dismutase and catalase). However, when ROS production exceeds the cell's ability to neutralize them, oxidative stress develops. Excess ROS damage: Lipids in membranes (lipid peroxidation) Proteins (protein cross-linking and degradation) DNA (creating mutations and lesions) Oxidative stress is a central feature of essentially all neurodegenerative disorders. Why Neurons Are Particularly Vulnerable Neurons are especially susceptible to oxidative damage because: High metabolic activity: Neurons use enormous amounts of ATP, particularly at synapses High oxygen consumption: To generate ATP, neurons continuously consume oxygen, producing ROS Weak antioxidant defenses: Neurons have relatively low levels of antioxidant enzymes compared to other cell types This creates a vulnerability unique to the nervous system. Apoptosis: The Intrinsic Mitochondrial Pathway When cells are stressed beyond recovery, mitochondria trigger programmed cell death through the intrinsic apoptotic pathway: Mitochondrial stress causes cytochrome c (a protein normally contained in mitochondria) to be released into the cytoplasm Cytochrome c activates caspase-9, an enzyme that initiates a cascade of protein degradation This cascading activation of caspases ultimately dismantles the cell in an organized fashion In neurodegeneration, this intrinsic mitochondrial apoptotic pathway is the predominant form of neuronal cell death. Additional Mitochondrial Functions Beyond ATP Beyond energy production, mitochondria also regulate: Calcium homeostasis: Mitochondria buffer intracellular calcium levels; dysfunction disrupts calcium signaling Mitochondrial dynamics: Fusion (joining mitochondria) and fission (dividing mitochondria) must remain balanced; imbalance leads to dysfunctional mitochondria accumulation Lipid composition: Mitochondrial membranes must maintain proper lipid ratios for function Permeability transition: Controlled permeability of the inner membrane; loss of control leads to mitochondrial dysfunction Dysfunction in any of these processes contributes to neurodegeneration. DNA Damage and Repair Deficiency Why DNA Damage Threatens Neurons The brain consumes roughly one-fifth of all oxygen inhaled by the body. This enormous oxygen consumption produces massive amounts of ROS, which in turn cause DNA damage—particularly oxidative DNA lesions. Most cells handle DNA damage by triggering cell division and letting daughter cells have fresh DNA. But neurons are post-mitotic: they do not divide. Once a neuron is mature, it cannot replace its DNA. This creates a critical vulnerability. Accumulation of DNA Lesions Because neurons cannot divide: Damaged DNA cannot be diluted out through cell division DNA lesions accumulate over time in long-lived neurons Accumulated DNA damage becomes a major risk factor for neurodegeneration This is particularly relevant in aging, where DNA repair mechanisms decline. DNA Repair Pathways and Age-Related Decline Cells have evolved sophisticated DNA repair pathways: Base excision repair (BER): Removes small lesions caused by oxidative damage Nucleotide excision repair (NER): Removes larger lesions such as those from UV damage With age, the efficiency of these repair pathways declines. This age-related decline in DNA repair leads to: Accumulation of oxidative DNA damage in the aging brain Increased risk of neurodegeneration This pattern is observed in both Alzheimer's disease and Parkinson's disease Genetic Links Between DNA Repair and Neurodegeneration Several neurodegenerative disorders are directly caused by defects in DNA repair: Ataxia-telangiectasia: Defect in DNA double-strand break repair Cockayne syndrome: Defect in nucleotide excision repair Xeroderma pigmentosum: Defect in nucleotide excision repair Amyotrophic lateral sclerosis (ALS): Some forms linked to DNA repair deficiency The pattern is clear: defective DNA repair → accumulation of DNA damage → neurodegeneration. Axonal Transport Impairment What is Axonal Transport? Axons are the long projections of neurons that transmit electrical signals. Axons can be extraordinarily long (some exceed 1 meter in length). Proteins, organelles, and nutrients must be transported along these axons from the cell body to distant axon terminals and back again. This transport occurs along microtubules (part of the neuronal cytoskeleton) via motor proteins: Kinesin drives transport toward the axon terminal (anterograde) Cytoplasmic dynein drives transport back toward the cell body (retrograde) Transport Defects in Neurodegeneration Axonal swellings and spheroids (enlargements along the axon) are observed in many neurodegenerative diseases. These indicate that axonal transport has failed. Transport can be disrupted by damage to any component: Motor proteins: Mutations or dysfunction in kinesin or dynein Microtubules: Structural damage to the cytoskeletal tracks Cargo proteins: Aggregates or misfolded proteins cannot be transported Mitochondria: Dysfunctional mitochondria cannot be transported and replaced Consequences: Wallerian-Like Degeneration Severe, prolonged transport failure triggers a degenerative cascade called Wallerian-like degeneration: The axon swells with accumulated cargo The axon becomes starved of ATP and building materials delivered from the cell body The distal (terminal) axon degenerates and dies This can progress to death of the entire neuron Transport impairment is particularly critical in neurons because of their extreme length and dependence on material delivery from the cell body. Shared Mechanisms Across Neurodegenerative Diseases Although different neurodegenerative diseases are caused by mutations in different genes and affect different brain regions, they converge on a remarkably small set of cellular mechanisms. Understanding these shared pathways is crucial because they represent potential therapeutic targets that could help multiple diseases. The Common Pathway: Mitochondrial Dysfunction → ROS → Oxidative Damage Impaired mitochondrial respiration leads to escalating problems: Mitochondria produce increased ROS as they struggle to function ROS accumulates, overwhelming antioxidant defenses Oxidative damage spreads to lipids, proteins, and DNA Multiple cellular systems fail simultaneously This cascade appears in Alzheimer's disease, Parkinson's disease, Huntington's disease, and ALS. The Common Pathway: DNA Damage and Repair Failure Accumulation of DNA double-strand breaks overwhelms neuronal repair pathways: Persistent DNA lesions accumulate (especially oxidative damage) Repair capacity is exceeded Cell cycle checkpoints cannot be satisfied Neurons initiate apoptosis (programmed death) or become dysfunctional Age-related decline in base excision repair and nucleotide excision repair is observed across multiple neurodegenerative conditions. The Common Pathway: Protein Aggregation → Toxicity Misfolded proteins generate a cascade of problems: Monomeric and oligomeric (small clustered) forms of α-synuclein, huntingtin, and tau accumulate These oligomers permeabilize membranes, forming pores that disrupt ion gradients Membrane disruption triggers mitochondrial dysfunction Mitochondrial dysfunction generates ROS (connecting back to the oxidative stress pathway) ROS causes further protein damage and misfolding (a vicious cycle) The Common Endpoint: Mitochondrial Apoptosis Most neurodegenerative diseases converge on the same cell death pathway: Mitochondrial outer membrane permeabilization (MOMP) occurs Cytochrome c is released into the cytoplasm Caspase cascades are activated The neuron is dismantled through apoptosis The specific trigger may differ between diseases (ROS, protein aggregates, DNA damage), but the final death pathway is shared. Summary: The Interconnected Network The mechanisms of neurodegeneration are not isolated processes but rather form an interconnected network. Mitochondrial dysfunction produces ROS, which damages DNA and proteins. Protein misfolding damages membranes, which disrupts mitochondria. Impaired protein degradation allows toxic proteins to accumulate. Each failure cascades into others, creating a self-reinforcing cycle of cellular damage that ultimately leads to neuronal death. This interconnected nature of neurodegenerative mechanisms explains why these diseases are so difficult to treat—fixing one problem may not help if others remain. It also suggests that effective therapies may need to target multiple points in this network simultaneously.